Clinical study of oxaliplatin combination with calcium folinate and flrorouracil in treatment of advanced esophageal carcinoma
10.3760/cma.j.issn.1008-6706.2011.13.009
- VernacularTitle:奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗中晚期食管癌的临床观察
- Author:
Yuxian YANG
;
Shuyao ZHANG
;
Shengqi ZHANG
;
Xiaowen ZHUANG
;
Xihui QIU
- Publication Type:Journal Article
- Keywords:
Esophageal neoplasms;
Oxaliplatin;
Leucovorin;
Fluorouracil
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(13):1745-1746
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and toxicity of oxaliplatin in combination with calcium folinate and flrDrouracil in treatment of advanced esophageal carcinoma. Methods 61 patients with advanced esophageal cancer were divided into treatment group ( 30 cases) and control group (31 cases). Treatment group was given oxaliplatin combined with calcium folinate and flrorouracil; control group was given cisplatin and calcium folinate and flrorouracil. Results The overall response rate was 43.3% in the treatment group and 41.9% in control group(P＞0.05).The median time to progression( TTP) was 8.1 months vs.7.9 months(P＞0.05).Compared with control group,the treatment group, the side effects of myelosuppression, stomasitis and alopecia were not significant difference (P ＞ 0. 05 ) , grade Ⅰ -Ⅳ nausea and vomiting( P = 0. 028 ) , diarrhea (P = 0. 039 ) and renal toxicity ( P = 0.044 ) were lower,while the peripheral nerve toxicity ( P = 0. 010) was higher. Conclusion The effect of oxaliplatin combined with calcium folinate and flrorouracil had satisfactory effect in the treatment of advanced esophageal carcinoma, and the poisonous side effect was low. It could be used as first-line chemotherapy regimen.
